Heritable defects in telomere and mitotic function selectively predispose to sarcomas

- Ballinger, Mandy L., Pattnaik, Swetansu, van der Graaf, Winette T. A., Fennelly, V, Wicht, A, Zielony, B, Galligan, E, Glavich, G, Stoeckert, J, Williams, L, Djandjgava, L, Buettner, I, Osinki, C, Puri, Ajay, Stephens, S, Rogasik, M, Bouclier, L, Girodet, M, Charreton, A, Fayet, Y, Crasto, S, Sandupatla, B, Yoon, Y, Je, N, Duffaud, Florence, Thompson, L, Fowler, T, Johnson, B, Petrikova, G, Hambridge, T, Hutchins, A, Bottero, D, Scanlon, D, Stokes-Denson, J, Génin, E, Le Cesne, Axel, Campion, D, Dartigues, J-F, Deleuze, J-F, Lambert, J-C, Redon, R, Ludwig, T, Grenier-Boley, B, Letort, S, Lindenbaum, P, Meyer, V, Seddon, Beatrice, Quenez, O, Dina, C, Bellenguez, C, Le Clézio, CC, Giemza, J, Chatel, S, Férec, C, Le Marec, H, Letenneur, L, Nicolas, G, Chandrasekar, Coonoor, Rouault, K, Schiffman, Joshua D., Brohl, Andrew S., James, Paul A., Kurtz, Jean-Emmanuel, Mundra, Piyushkumar A., Penel, Nicolas, Myklebost, Ola, Meza-Zepeda, LA, Pickett, H, Kansara, M, Waddell, N, Kondrashova, O, Pearson, JV, Barbour, AP, Li, S, Zaheed, Milita, Nguyen, TL, Fatkin, D, Graham, RM, Giannoulatou, E, Green, MJ, Kaplan, W, Ravishankar, S, Copty, J, Powell, JE, Cuppen, E, Rath, Emma, van Eijk, K, Veldink, J, Ahn, J-H, Kim, JE, Randall, RL, Tucker, K, Judson, I, Sarin, R, Genin, E, Priestley, Peter, French Exome Project Consortium,, Haber, M, Marshall, G, Cairns, Murray J., Blay, J-Y, International Sarcoma Kindred Study,, Thomas, DM, Tattersall, M, Neuhaus, S, Baber, Jonathan, Lewis, C, Carey-Smith, R, Wood, D, Porceddu, S, Dickinson, I, Thorne, H, James, P, Ray-Coquard, I, Ray-Coquard, Isabelle, Cassier, P, Le Cesne, A, Duffaud, F, Penel, N, Isambert, N, Kurtz, J-E, Puri, A, Isambert, Nicholas, Ward, I, van der Graaf, W, Seddon, B, Chandrasekar, C, Rickar, R, Hennig, I, Schiffman, J, Silvestri, A, Causeret, Sylvain, Zaratzian, A, Tayao, M, Walwyn, K, Niedermayr, E, Mang, D, Clark, R, Thorpe, T, MacDonald, J, Riddell, K, Mar, J

Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

- Chen, Jingwei, Nelson, Christopher, Wong, Matthew, Tee, Andrew E., Liu, Pei Y., La, Ting, Fletcher, Jamie I., Kamili, Alvin, Mayoh, Chelsea, Bartenhagen, Christoph, Trahair, Toby N., Xu, Ning, Jayatilleke, Nisitha, Wong, Marie, Peng, Hui, Atmadibrata, Bernard, Cheung, Belamy B., Lan, Qing, Bryan, Tracy M., Mestdagh, Pieter, Vandesompele, J, Combaret, V, Boeva, V, Wang, JY, Janoueix-Lerosey, I, Cowley, MJ, MacKenzie, KL, Dolnikov, A, Li, J, Polly, P, Marshall, GM, Reddel, RR, Norris, MD, Haber, M, Fischer, M, Zhang, Xu D., Pickett, HA, Liu, T